Company / Cash per Share
Amgen Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$17.00
FY2025
5-year range
$13.66 / $22.36
FY2021-FY2025
Trend
-24.0%
vs FY2024
Sector context
#11 of 207
Health Care
What the data says
Among 207 Health Care companies, Amgen is in the top 5% for cash per share. Cash per Share has fluctuated over the past 10 years, ranging from $4.30 in FY2016 to $22.36 in FY2024.
Based on SEC 10-K filings.
17.00 in FY2025 with a 5-year CAGR of +9.9%. Top quartile in the Health Care sector.
Declined from $20.49 to $17.00 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +7.6%
- 5-Year CAGR
- +9.9%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 207This company $17.00 Sector average $67.39
▼
-74.8% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 24.0% year-over-year.
- Ranks #11 out of 207 companies in the Health Care sector.
- Peak cash per share was recorded in FY2024.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.00 | -24.0% |
| FY2024 | $22.36 | +9.1% |
| FY2023 | $20.49 | +50.0% |
| FY2022 | $13.66 | -1.1% |
| FY2021 | $13.81 | +30.4% |
| FY2020 | $10.60 | +10.5% |
| FY2019 | $9.59 | -0.3% |
| FY2018 | $9.62 | +86.8% |
| FY2017 | $5.15 | +19.8% |
| FY2016 | $4.30 | -21.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026